Page 20 - Astrazeneca

Airlines face 'mission of the century' in shipping coronavirus vaccines

United Airlines Holdings Inc. has begun flights to ready Pfizer's vaccine for distribution if it receives regulatory approval, said a person familiar with the matter

Inform people about vaccine in simple language, PM tells manufacturers

Serum Institute in Pune will undertake mass production of Covishield vaccine developed by Oxford-Astra Zeneca

Who will get Covid vaccine first? Serum CEO on distribution, pricing & Modi

Oxford vaccine: Serum to apply for emergency-use authorisation in 2 weeks

Serum Institute CEO Adar Poonawalla makes the announcement after a meeting with PM Narendra Modi, who was visiting key vaccine sites in India

Volunteer for Oxford's Covid-19 vaccine seeks Rs 5 crore compensation

Vaccine 'Covishield' is being manufactured by Pune-based Serum Institute of India

India Coronavirus Dispatch: What does '90% efficacy' for a vaccine mean?

Students aspiring to study abroad may face tougher competition in 2021, AstraZeneca's manufacturing error casts doubt over its potential, and other news relevant to India's fight against the pandemic

Suspected North Korean hackers targeted vaccine maker AstraZeneca: Report

The hackers posed as recruiters on networking site LinkedIn and WhatsApp to approach AstraZeneca staff with fake job offers

Covid updates on vaccine, lockdown chances and PM's Serum institute visit

Russia's sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year of Russia's Covid vaccine Sputnik V, in India

CEO says AstraZeneca may to run new global trial of Covid vaccine: Report

AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage amid questions over the results from its late-stage study

Top headlines: Modi to visit Serum Institute, farmers' protests, more

Union Agriculture Minister Narendra Singh Tomar said the government is ready to talk with farmers on December 3, and resolve differences

Britain asks regulator to assess AstraZeneca-Oxford vaccine amid questions

The British government said it has formally asked the country's medicines regulator to assess whether a coronavirus vaccine developed by AstraZeneca and Oxford University should be authorised for use

Russia's Sputnik V developers call on AstraZeneca to try combining vaccines

Russia said its Sputnik V vaccine is 92% effective at protecting people from COVID-19, according to interim trial results

CEO says AstraZeneca likely to run new global Covid vaccine trial: Report

"Now that we've found what looks like a better efficacy we have to validate this, so we need to do an additional study," Soriot was quoted as saying

AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: SII

Serum Institute of India said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly

AstraZeneca aims to impact 10 mn diabetics by 2023, starts awareness drive

India will have 115 mn diabetics by 2030. Forty-four per cent of patients hospitalised for heart failure have type-2 diabetes

Thailand to sign Covid-19 vaccine agreement with Oxford-AstraZeneca

The announcement comes as other countries in the region like the Philippines prepare to sign similar deals with AstraZeneca

Top headlines: Questions over Oxford vaccine data, Vedanta under pressure

Modi bats for One Nation One Election, Keki Mistry says NPAs in real estate will inch up , and more top headlines of the day

AstraZeneca faces more Covid-19 vaccine questions after manufacturing error

Oxford said a difference in manufacturing processes led to later phases of the trials having a half-dose given instead of a full one

AstraZeneca Covid-19 vaccine's 90% efficacy came in younger trial group

The vaccine being developed with Oxford University was 90 per cent effective when a half-dose was given before a full-dose booster, the partners said on Monday

India Coronavirus Dispatch: How do you vaccinate a billion people?

AstraZeneca's manufacturing error, lack of transparency in Indian vaccine trials, should Indian states consider lockdowns again?-news relevant to India's fight against Covid-19